Menu
Back to Equity and Access
06/01/26

Perspectives of United States dermatologists on melanoma screening and overdiagnosis: a qualitative study.

Labrada, Jocelyn; Mandaloju, Srivani; Brandt Ryborg Jønsson, Alexandra; Brandt Brodersen, John; Cust, Anne E; Tsevat, Joel; Pignone, Michael P; Adamson, Adewole S. Skin Health Disease.

Collection Topics
Big Three Conditions Overdiagnosis Tests, Screening, and Laboratory Processes
Share

Most recent

Primary care signals and diagnostic pathways before incident heart failure: a systematic scoping review.

Jerjes, El-Osta, Jhass, et al., J Prim Care Community Health.
09/09/26 Big Three Conditions Culture, Work System, and Implementation Epidemiology

A business case for diagnostic stewardship: a practical guide from the Society for Healthcare Epidemiology of America (SHEA) Diagnostic Stewardship Special Interest Group.

Turbett, Daragiati, T. Chu, et al., Antimicrob Steward Healthc Epidemiol.
09/01/26 Business Case for Excellence Tests, Screening, and Laboratory Processes

Young women diagnosed with breast cancer: why is no one telling me to get a mammogram?

Jerome-D'Emilia, Suplee, Meyers, et al., J Nurs Scholarsh.
09/01/26 Big Three Conditions Equity, Access, and Timeliness

Summary

More cancer detection does not automatically mean better outcomes. This qualitative study interviewed 15 board-certified dermatologists about melanoma screening and overdiagnosis. Participants described screening’s perceived benefits while grappling with limited evidence that population-based screening reduces mortality. The findings highlight challenges in communicating overdiagnosis and balancing early detection against potential overtreatment.
Read the paper
Labrada J, Mandaloju S, Brandt Ryborg Jønsson A, et al. Perspectives of United States dermatologists on melanoma screening and overdiagnosis: a qualitative study. Skin Health Disease. 2026;6(3):298-305.